MET MetLife Inc.

MetLife, Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe Investigates Possible Breaches of Fiduciary Duty by Officers and Directors

Former United States Securities and Exchange Commission attorney Willie Briscoe, founder of The Briscoe Law Firm, PLLC, announces that a federal class action lawsuit has been filed in the United States District Court for the Eastern District of New York against MetLife, Inc. (“MetLife” or “Company”) (NYSE: MET) and several officers and directors for acts taken during the period of February 27, 2013 and January 29, 2018 (the “Class Period”).

Based upon the allegations in the class action, the firm is investigating additional legal claims against the officers and Board of Directors of MetLife. If you are an affected MetLife shareholder and want to learn more about the lawsuit or join the action, contact Willie Briscoe at The Briscoe Law Firm, PLLC via email at [email protected] or call toll free at (888) 809-2750. There is no cost or fee to you.

In the complaint, the defendants are alleged to have violated certain provisions of the Securities Exchange Act of 1934. Specifically, the complaint alleges, among other things, that defendants misrepresented and/or failed to disclose during the Class Period that: (1) MetLife’s practices and procedures used to estimate its reserves set aside for annuity and pension payments were inadequate; (2) MetLife had inadequate internal controls over financial reporting; and (3) as a result, Defendants’ statements about MetLife’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

On December 15, 2017, after-market, MetLife announced that the Company had been unable to locate some of the Company’s annuity beneficiaries and the Wall Street Journal published an article regarding the disclosure. On January 29, 2018, after-market, MetLife announced it would reschedule its earnings releases for fourth quarter and full year 2017, due to “material weaknesses” in its internal controls. The Company also advised it would have to revise certain of its prior financial statements, and that the Securities and Exchange Commission and the New York Department of Financial Services had made related inquiries. On this news, shares of MetLife fell $0.62 per share, or over 1.2%, over the following two trading days to close at $50.79 per share on December 19, 2017.

The Briscoe Law Firm, PLLC is a full service business litigation, commercial transaction, and public advocacy firm with more than 20 years of experience in complex litigation and transactional matters.

EN
09/02/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on MetLife Inc.

Moody’s Ratings assigns ratings to MetLife’s shelf (senior unsecured a...

Moody’ s Ratings assigns ratings to MetLife’ s shelf. New York, January 5, 2026– Moody’ s Ratings has assigned provisional ratings to. MetLife, Inc.’ s shelf registration filed on May 16, 2025.

MarketLine Department
  • MarketLine Department

The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (...

Summary Marketline's The Hartford Financial Services Group, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by The Hartford Financial Services Group, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances since January2007. Marketline's Company Mergers & Acquisit...

Metlife Inc: 1 director

A director at Metlife Inc sold/gave away 30,684 shares at 0.000USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

Moody's Ratings rates MetLife’s subordinated debentures Baa1(hyb), sta...

New York , March 11, 2025 – Moody's Ratings (Moody's) has assigned a Baa1(hyb) rating to the subordinated debentures issued by MetLife, Inc. (MetLife, NYSE: MET, senior debt A3). The debentures are being issued off MetLife's multi-purpose shelf registration statement filed in November 2022 and the p...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch